agm

Chairman's Address
I would first and foremost like to thank you all far attending our 4th AGM and for your continued support in a trying environment.

We are all aware the past 12 months have seen our share price deteriorate to levels that no one in this room is happy about. This has been partly due to market factors such as the mining boom and the negative perception of biotechnology companies in general but it has not been helped by the slower than expected generation of revenues from sales of Ovine Collagen products.
mining boom aid the negative perception of biotechnology companies in general but it has Collagen products.

Colltech have made a number of key strategic moves to turn this around over the past 12 months. These changes such as strengthening the marketing expertise at board and management level, Implementing a global Distribution and sales strategy, reviewing the product range and development programs; are now starting to take effect.

Operationally the progress is very exciting. Dr Cooper will provide you with a more detailed update at the completion of this meeting but I would like to point out that CollTech are now represented in 15 countries around the world, we have over 30 companies currently evaluating our Collagen with over 18 companies planning to release products using our Collagen. We have a number of research agreements now in place looking at medical applications using our Collagen (even before we have a medical grade collagen). We have released two new products in the past 12 months and yesterday we received Halal certification for our cosmetic Collagens.

The company is in a very strong position to move forward and the board is confident of the
potential of the company.

With that I would like to declare the meeting Open and move on to the business of the meeting.

= = = = = = = = = = = = = = = = = = = = = = = = = = = = =

Distributor Status
Distributor/Region/Date of agreement-letter of intent/Assessing Samples/Products in Development/Products being Market Tested/Released Products for sale
Elgin/Taiwan/March/7/7/1/1
Behn Meyer/Thailand/May/19/7/2/Q108
Ziko/Korea/May/4/4/1/Q108
Nardev Chemie/Singapore, Malaysia, Vietnam, Indonesia/May/5/
Yasham Bio-Science/India/October/yes (assessing samples)
Angem Specialties/India/October/yes (assessing samples)
Bio Alliance/USA/November/
Beauty Essence/Poland/Pending/

= = = = = = = = = = = = = = = = = = = = = = = = = = = = =

• OVICOLL® is a safe, innovative and superior product
• Significant and growing market for collagen
• OVICOLL® is available now and being used for commercial purposes
• Product development is ahead of schedule
• Engagement of potential partners and product developers for medical grade collagen will occur prior to the launch of this material in 2008
• CollTech will generate revenue from product sales and is positioned for growth in CY08